CRBU - Caribou Biosciences, Inc.
IEX Last Trade
1.655
0.020 1.208%
Share volume: 26,405
Last Updated: Fri 27 Dec 2024 08:30:06 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$1.64
0.02
1.22%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-08 | 2023-03-09 | 2023-05-09 | 2023-08-08 | 2023-11-07 | 2024-03-11 | 2024-05-07 | |
| Assets | |||||||||
| Total Assets | 421.367 M | 398.823 M | 373.765 M | 347.462 M | 349.647 M | 457.521 M | 432.209 M | 406.825 M | |
| Current Assets | 352.928 M | 306.922 M | 260.248 M | 239.490 M | 268.538 M | 350.693 M | 338.841 M | 304.514 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 9.386 M | 10.457 M | 10.168 M | 7.749 M | 7.045 M | 8.727 M | 7.580 M | 7.884 M | |
| Short Term Investments | 9.386 M | 10.457 M | 10.168 M | 7.749 M | 7.045 M | 8.727 M | 7.580 M | 7.884 M | |
| Total Receivables | 3.618 M | 3.096 M | 2.417 M | 3.203 M | 2.261 M | 3.478 M | 2.434 M | 2.642 M | |
| Current Cash | 339.924 M | 293.369 M | 247.663 M | 228.538 M | 259.232 M | 338.488 M | 328.827 M | 293.988 M | |
| Total Non-current Assets | 68.439 M | 91.901 M | 113.517 M | 107.972 M | 81.109 M | 106.828 M | 93.368 M | 102.311 M | |
| Property Plant Equipment | 8.006 M | 8.959 M | 10.678 M | 12.646 M | 15.429 M | 16.598 M | 18.270 M | 19.167 M | |
| Other Assets | 26.553 M | 25.962 M | 25.768 M | 25.191 M | 24.625 M | 24.248 M | 23.768 M | 23.453 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 421.367 M | 398.823 M | 373.765 M | 347.462 M | 349.647 M | 457.521 M | 432.209 M | 406.825 M | |
| Total liabilities | 73.478 M | 74.709 M | 72.894 M | 69.190 M | 80.189 M | 59.253 M | 63.808 M | 63.536 M | |
| Total current liabilities | 28.855 M | 28.814 M | 28.128 M | 27.100 M | 34.375 M | 24.572 M | 28.302 M | 29.021 M | |
| Accounts Payable | 426.000 K | 1.228 M | 1.146 M | 2.651 M | 4.433 M | 2.377 M | 3.120 M | 5.940 M | |
| Other liabilities | 17.058 M | 18.462 M | 17.605 M | 15.307 M | 19.279 M | 7.984 M | 9.041 M | 8.064 M | |
| Current long term debt | 877.000 K | 912.000 K | 966.000 K | 1.022 M | 1.079 M | 1.139 M | 1.200 M | 1.264 M | |
| Long term debt | 27.090 M | 26.958 M | 26.780 M | 26.401 M | 26.155 M | 26.316 M | 25.908 M | 25.895 M | |
| Other liabilities | 17.058 M | 18.462 M | 17.605 M | 15.307 M | 19.279 M | 7.984 M | 9.041 M | 8.064 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 347.889 M | 324.114 M | 300.871 M | 278.272 M | 269.458 M | 398.268 M | 368.401 M | 343.289 M | |
| Common stock | 60.758 M | 60.887 M | 61.014 M | 61.187 M | 61.418 M | 83.784 M | 88.842 M | 89.303 M | |
| Retained earnings | -143.579 M | -170.226 M | -197.215 M | -225.259 M | -254.778 M | -264.780 M | -299.285 M | -340.519 M |